Predictive biomarkers for <scp>5‐ALA‐PDT</scp> can lead to personalized treatments and overcome tumor‐specific resistances

Abstract

This study demonstrates the heterogeneity in the cellular response to 5-ALA-PDT and identifies biomarkers that may be used to predict treatment outcome. The study also provides preliminary findings on the potential of inhibiting specific molecular targets to overcome inherent resistances to 5-ALA-PDT.